BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 16375642)

  • 1. Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients.
    Stögbauer F; Geß B; Brambs C; Lautizi M; Kacprowski T; Ourailidis I; Bronger H; Kiechle M; Noske A; Keller G; Jesinghaus M; Poremba C; Weichert W; Boxberg M
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2.
    Clarfield L; Diamond L; Jacobson M
    Curr Oncol; 2022 Mar; 29(3):2132-2140. PubMed ID: 35323372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?
    Mitra S; Lami MS; Ghosh A; Das R; Tallei TE; Fatimawali ; Islam F; Dhama K; Begum MY; Aldahish A; Chidambaram K; Emran TB
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers.
    Kooshkaki O; Derakhshani A; Safarpour H; Najafi S; Vahedi P; Brunetti O; Torabi M; Lotfinejad P; Paradiso AV; Racanelli V; Silvestris N; Baradaran B
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological aspects of the outcomes from the treatment of endometriosis: Experience from two different geographical areas.
    Matalliotaki C; Matalliotakis M; Zervou MI; Patelarou A; Koliarakis I; Spandidos DA; Arici A; Matalliotakis I; Goulielmos GN
    Exp Ther Med; 2020 Feb; 19(2):1079-1083. PubMed ID: 32010272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-Spondin Is the Signal by Which 2-Methoxyestradiol Induces Apoptosis in the Endometrial Cancer Cell Line Ishikawa.
    Rincón-Rodriguez R; Mena D; Mena J; Díaz-Saldivar P; Guajardo-Correa E; Godoy-Guzman C; Cardenas H; Orihuela PA
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31394756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2ME and 2OHE2 exhibit growth inhibitory effects and cell cycle arrest at G2/M in RL95-2 human endometrial cancer cells through activation of p53 and Chk1.
    Gong QF; Liu EH; Xin R; Huang X; Gao N
    Mol Cell Biochem; 2011 Jun; 352(1-2):221-30. PubMed ID: 21344307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study.
    Zannoni GF; Vellone VG; Arena V; Prisco MG; Scambia G; Carbone A; Gallo D
    Virchows Arch; 2010 Jul; 457(1):27-34. PubMed ID: 20552366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium.
    Kato S; Sadarangani A; Lange S; Villalón M; Brañes J; Brosens JJ; Owen GI; Cuello M
    Endocr Relat Cancer; 2007 Jun; 14(2):351-68. PubMed ID: 17639050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
    Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
    Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endometrial cancer in HNPCC syndrome].
    Lécuru F; Ansquer Y; Bats AS; Olschwang S; Laurent-Puig P; Eisinger F
    J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):547-53. PubMed ID: 18650032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine artery embolization as a treatment option for uterine myomas.
    Marshburn PB; Matthews ML; Hurst BS
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of uterine cancer and its management.
    Carter J; Pather S
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):33-42. PubMed ID: 16375642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial cancer and its management.
    Pather S; O'Leary M; Carter J
    Womens Health (Lond); 2007 Jan; 3(1):45-54. PubMed ID: 19803864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical therapy of endometrial cancer].
    Büttner HH
    Zentralbl Gynakol; 1987; 109(7):432-7. PubMed ID: 3617990
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.